Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
112.71
-0.24 (-0.21%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $7.81 billion as of July 26, 2024. Its market cap has increased by 36.27% in one year.
Market Cap
7.81B
Enterprise Value
7.75B
1-Year Change
36.27%
Ranking
Category
Stock Price
$112.71
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $7.81B, an increase of 4,266.81%. That is a compound annual growth rate of 51.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 7.83B | 84.37% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intra-Cellular Therapies | 8.53B |
| Bio-Rad Laboratories | 8.34B |
| Chemed | 8.19B |
| Cerevel Therapeutics Holdings | 8.09B |
| Roivant Sciences | 7.93B |
| The Ensign Group | 7.75B |
| Ascendis Pharma | 7.61B |
| Ionis Pharmaceuticals | 7.57B |